Literature DB >> 2072787

Peptic ulcer pathophysiology.

H R Mertz1, J H Walsh.   

Abstract

Despite extensive research, the etiology of peptic ulcer disease remains unclear. Given the multiple processes that control acid and pepsin secretion and defense and repair of the gastroduodenal mucosa, it is likely that the cause of ulceration differs between individuals. Acid and pepsin appear to be necessary but not sufficient ingredients in the ulcerative process. It is clear that the majority of gastric ulcers and a substantial number of duodenal ulcers do not have increased gastric acid secretion. Recent research has focused more on protection and repair of the stomach and duodenum. NSAIDs cause a significant number of gastric and duodenal ulcers; this is probably due to inhibition of prostaglandin production with loss of its protective effects. In the absence of NSAIDs and gastrinoma, it appears that most gastric ulcers and all duodenal ulcers occur in the setting of H. pylori infection. Evidence is mounting in support of H. pylori as a necessary ingredient in the ulcerative process, similar to acid and pepsin. It is not known whether the bacteria or the accompanying inflammation is the more important factor in the pathophysiology. Although the pathophysiology of gastric ulcer and duodenal ulcer is similar, there are clearly differences between the two groups. Duodenal ulcer is typified by H. pylori infection and duodenitis and in many cases impaired duodenal bicarbonate secretion in the face of moderate increases in acid and peptic activity. These facts suggest the following process: increased peptic activity coupled with decreased duodenal buffering capacity may lead to increased mucosal injury and result in gastric metaplasia. In the presence of antral H. pylori, the gastric metaplasia can become colonized and inflamed. The inflammation or the infection itself then disrupts the process of mucosal defense or regeneration resulting in ulceration. A cycle of further injury and increased inflammation with loss of the framework for regeneration may then cause a chronic ulcer. Gastric ulcer often occurs with decreased acid-peptic activity, suggesting that mucosal defensive impairments are more important. The combination of inflammation, protective deficiencies, and moderate amounts of acid and pepsin may be enough to induce ulceration. Many questions remain in understanding the pathophysiology of peptic ulcer disease. The physiology and pathophysiology of mucosal regeneration and the mechanisms by which H. pylori and inflammation disrupt normal gastroduodenal function will be fruitful areas of future investigation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2072787     DOI: 10.1016/s0025-7125(16)30412-6

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  12 in total

1.  Antacid effects of Chinese herbal prescriptions assessed by a modified artificial stomach model.

Authors:  Tsung-Hsiu Wu; I-Chin Chen; Lih-Chi Chen
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

2.  Can Eradication of Helicobacter pylori Prevent Gastric Cancer?

Authors:  Raul Leon-Barua; Sixto Recavarren-Arce; Robert H Gilman; Roberto Berendson
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

Review 3.  Formulary management of antiulcer drugs: clinical considerations.

Authors:  S L Sankey; L S Friedman
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

Review 4.  Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.

Authors:  L B Barradell; D McTavish
Journal:  Pharmacoeconomics       Date:  1993-06       Impact factor: 4.981

Review 5.  Ranitidine: a pharmacoeconomic evaluation of its use in acid-related disorders.

Authors:  J E Frampton; D McTavish
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

6.  Gastrointestinal comorbidities in patients with psoriatic arthritis.

Authors:  Ariel Zohar; Arnon Dov Cohen; Haim Bitterman; Ilan Feldhamer; Sari Greenberg-Dotan; Idit Lavi; Doron Comanesther; Erez Batat; Devy Zisman
Journal:  Clin Rheumatol       Date:  2016-08-17       Impact factor: 2.980

7.  Gastric juice acidity in upper gastrointestinal diseases.

Authors:  Pei-Jung Lu; Ping-I Hsu; Chung-Hsuan Chen; Michael Hsiao; Wei-Chao Chang; Hui-Hwa Tseng; Kung-Hung Lin; Seng-Kee Chuah; Hui-Chun Chen
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

8.  Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study.

Authors:  J J Chen; C S Changchien; D I Tai; S S Chiou; C M Lee; C H Kuo
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

9.  Murine endoscopy for in vivo multimodal imaging of carcinogenesis and assessment of intestinal wound healing and inflammation.

Authors:  Markus Brückner; Philipp Lenz; Tobias M Nowacki; Friederike Pott; Dirk Foell; Dominik Bettenworth
Journal:  J Vis Exp       Date:  2014-08-26       Impact factor: 1.355

10.  The Influence of Antral Ulcers on Intramural Gastric Nerve Projections Supplying the Pyloric Sphincter in the Pig (Sus scrofa domestica)-Neuronal Tracing Studies.

Authors:  Michal Zalecki
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.